4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
AN2 Therapeutics, Inc. (ANTX) operates in the Biotechnology industry and is headquartered in Menlo Park, United States with about 21 employees. Its market capitalization is roughly $177 million. In the fiscal year ended 2025-12-31, ANTX reported $0M in revenue and ($35M) in net income.
AN2 Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($38M) | ($55M) | ($70M) | ($42M) | — |
| Net Income | ($35M) | ($51M) | ($65M) | ($41M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($11M) | ($9M) | ($10M) | ($7M) | ($12M) | — |
| Net Income | ($10M) | ($9M) | ($9M) | ($6M) | ($11M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $62M | $92M | $139M | $103M | — |
| Total Liabilities | $9M | $10M | $14M | $7M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ANTX viewer.
About TickerBase · Data methodology & sources